- Trials with a EudraCT protocol (1,076)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
1,076 result(s) found for: Data collection.
Displaying page 1 of 54.
EudraCT Number: 2021-005613-14 | Sponsor Protocol Number: REUM-2021-01 | Start Date*: 2023-03-13 |
Sponsor Name: | ||
Full Title: Immune-Related Rheumatological Adverse Events study. Data collection from patients with cancer to evaluate rheumatological adverse events in patients treated with immune-checkpoint inhibitors. | ||
Medical condition: Any cancer patients starting immune checkpoint inhibitor therapy (ICI-therapy). Any patient exhibiting a rheumatological immune-related adverse event (R-irAE). Patients with newly developed rheum... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2020-004929-23 | Sponsor Protocol Number: 2020/1002 | Start Date*: 2021-04-14 |
Sponsor Name:University Medical Center Groningen | ||
Full Title: Individual albuminuria lowering response to dapagliflozin in a decentralized clinical trial in patients with type 2 diabetes mellitus and elevated albuminuria | ||
Medical condition: Patients with type 2 diabetes and albuminuria >20 mg/g (2.26 mg/mmol) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2017-005005-12 | Sponsor Protocol Number: D2.D12.Bemfola | Start Date*: 2018-05-28 | ||||||||||||||||
Sponsor Name:UZ Brussel | ||||||||||||||||||
Full Title: Initiation of ovarian stimulation with recombinant-human FSH (Bemfola®) in the late follicular phase, a randomised controlled study. | ||||||||||||||||||
Medical condition: Subfertility Oocyte donation | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Female | |||||||||||||||||
Trial protocol: BE (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-001195-13 | Sponsor Protocol Number: 21651 | Start Date*: 2005-08-18 |
Sponsor Name:University of Leeds | ||
Full Title: The Leeds Evaluation of Efficacy of Detoxification Study (LEEDS) Prisons Project: An open label pragmatic randomised control trial comparing the efficacy of differing therapeutic agents for prison ... | ||
Medical condition: Opiate addiction (detoxification from illicit opiates) | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2014-004357-13 | Sponsor Protocol Number: CTH201401 | Start Date*: 2015-03-18 | |||||||||||
Sponsor Name:Odense University Hospital | |||||||||||||
Full Title: Coagaulation in patients with atrial fibrillation: The effect of dabigatran | |||||||||||||
Medical condition: Atrial fibrillation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-005295-32 | Sponsor Protocol Number: TRALIS001 | Start Date*: 2006-02-01 |
Sponsor Name:Research and Development Department, Addenbrookes NHS Foundation Trust | ||
Full Title: Trial in rheumatoid arthritis of lisinopril (TRALIS) | ||
Medical condition: Rheumatoid arthritis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2020-001434-35 | Sponsor Protocol Number: Hydroxycholoquin-COVID-19 | Start Date*: 2020-03-31 |
Sponsor Name:Cliniques universitaires Saint-Luc | ||
Full Title: Monocentric Population Pharmacokinetic study of Hydroxychloroquine in COVID-19 Patients to inform its dosing optimization. | ||
Medical condition: Subject tested positive for COVID-19 | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2016-000996-26 | Sponsor Protocol Number: VAB1 | Start Date*: 2016-09-01 |
Sponsor Name:Region Ostergotland | ||
Full Title: Volumekinetics for hyperoncotic albumin in burn patients as well as for healthy subjects. | ||
Medical condition: Healthy adult volunteers and burn patients 3 to 10 Days after the injury. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: View results |
EudraCT Number: 2018-000388-10 | Sponsor Protocol Number: WADA_17C09 | Start Date*: 2019-06-11 |
Sponsor Name:Daniel Sanabria | ||
Full Title: Clinical trial on the effects of the tramadol and paracetamol on physical, cognitive and brain performance during cycling | ||
Medical condition: Sports doping | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2013-003866-15 | Sponsor Protocol Number: ABI-007-PANC-CA046C | Start Date*: 2014-01-24 | |||||||||||
Sponsor Name:Celgene Corporation | |||||||||||||
Full Title: MPACT EXTENSION STUDY: MULTICENTER, SURVIVAL DATA COLLECTION IN SUBJECTS PREVIOUSLY ENROLLED IN PROTOCOL CA046 | |||||||||||||
Medical condition: Metastatic Adenocarcinoma of the Pancreas | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) ES (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-003381-27 | Sponsor Protocol Number: 100045 | Start Date*: 2018-09-24 |
Sponsor Name:CEA | ||
Full Title: Study in 18F-DPA714 PET to better locate preoperatively the epileptic focus to resect in drug-resistant partial epilepsy | ||
Medical condition: Brain imaging on people with partial pharmaco resistant epilepsy | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: FR (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2022-003581-20 | Sponsor Protocol Number: ALPHA | Start Date*: 2023-03-21 |
Sponsor Name:Medical University Vienna | ||
Full Title: Albendazole pharmacokinetics in plasma, intra-cystic fluid, and cystic tissue of human cystic and alveolar echinococcosis | ||
Medical condition: Albendazole is an orally administered broad-spectrum anthelmintic Drug used in treatment of human alveolar and cystic echinococcosis. To date, data on albendazole and tissue pharmacokinetics are li... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2020-005772-35 | Sponsor Protocol Number: LINEZOLID01 | Start Date*: 2021-04-21 |
Sponsor Name:UCLouvain | ||
Full Title: Study on linezolid use and adverse drug reactions in clinical practice: Follow-up of patients treated in Belgian Hospitals | ||
Medical condition: All infections treated with the antibiotic linezolid | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2014-001290-14 | Sponsor Protocol Number: EMR200136_583 | Start Date*: 2014-10-24 |
Sponsor Name:MERCK ROMANIA SRL | ||
Full Title: Prospective Phase IV Clinical Trial on Effectiveness of Rebif Treatment of CIS and RMS Patients in Romania using Electronic Device RebiSmart™ | ||
Medical condition: Clinical isolated syndrome and relapse multiple sclerosis | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: RO (Completed) | ||
Trial results: View results |
EudraCT Number: 2017-002248-34 | Sponsor Protocol Number: FInCH | Start Date*: 2018-02-20 | |||||||||||||||||||||
Sponsor Name:King's College London | |||||||||||||||||||||||
Full Title: FInCH Study: A randomised feasibility study comparing fluoride interventions to prevent dental decay in older people in care homes. | |||||||||||||||||||||||
Medical condition: Prevention of dental decay in older people in care homes | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-003349-12 | Sponsor Protocol Number: NUIG-2020-003 | Start Date*: 2020-10-09 |
Sponsor Name:NUIG | ||
Full Title: Can Nebulised HepArin Reduce acuTE lung injury in Patients with SARS-CoV-2 Requiring Advanced Respiratory support in Ireland | ||
Medical condition: This trial will be carried out in invasively ventilated ICU patients with suspected or confirmed COVID-19 infection | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IE (Completed) | ||
Trial results: View results |
EudraCT Number: 2004-005188-12 | Sponsor Protocol Number: Clinical Protocol | Start Date*: 2005-02-25 |
Sponsor Name:University of Leeds | ||
Full Title: DENTAL TRAUMA: The effectiveness of an internet based computer database for data collection in a randomised controlled trail to evaluate immediate extirpation of necrotic pulp tissue and placement ... | ||
Medical condition: Tooth Avulsion and Replantation | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2010-023262-46 | Sponsor Protocol Number: 20101005PH | Start Date*: 2011-03-08 |
Sponsor Name:Royal Devon & exeter Foundation trust | ||
Full Title: A Randomised Prospective Pilot Study Comparing the Outcomes of Patients with Lumbar Nerve Root Pain Secondary to Lumbar Disc Prolapse Treated by Nerve Root Block with or without the Addition of Clo... | ||
Medical condition: Lumbar nerve root pain secondary to disc prolapse. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2014-001737-88 | Sponsor Protocol Number: CYD57 | Start Date*: 2014-05-26 |
Sponsor Name:Sanofi Pasteur SA | ||
Full Title: Long-Term Safety Follow-Up of Thai Children Who Were Included in an Efficacy Study of a Tetravalent Dengue Vaccine | ||
Medical condition: Prevention of symptomatic dengue disease | ||
Disease: | ||
Population Age: Children, Under 18 | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2010-019180-10 | Sponsor Protocol Number: NCTU5248 | Start Date*: 2010-07-29 |
Sponsor Name:The Newcastle upon Tyne Hospitals NHS Foundation Trust | ||
Full Title: Paramedic Initiated Lisinopril For Acute Stroke Treatment(PIL-FAST): A Pilot Randomised Controlled Trial | ||
Medical condition: Stroke and high blood pressure | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
